药捷安康-B(02617.HK)获纳入恒生指数系列成份股
TRANSTHERA-BTRANSTHERA-B(HK:02617) Jin Rong Jie·2025-08-25 14:54

Core Viewpoint - The company,药捷安康-B (02617.HK), has been selected to be included in the Hang Seng Index series, effective from September 8, 2025, as announced by Hang Seng Indexes Company on August 22, 2025 [1] Group 1 - The inclusion in the Hang Seng Index series is expected to enhance the company's visibility and credibility in the market [1] - This selection may lead to increased investment interest and potential stock price appreciation for the company [1]